Vanderbilt Institute for Clinical and Translational Research (VICTR)

June 16, 2022

Researchers add sign language videos to electronic surveys

A new external module in Vanderbilt’s REDCap improves electronic survey accessibility for respondents who are deaf. The module makes it easy to embed individual sign language videos for each survey question and answer.

By Paul Govern
VUMC’s new automated biobanking system can store as many as 10 million biospecimens.
April 6, 2022

Major grant renewal to provide five more years of support for VICTR

Vanderbilt University Medical Center has competed successfully for a third renewal of its Clinical and Translational Science Award by the National Institutes of Health.

By Bill Snyder
November 11, 2021

Translational Research Forum honors scientific excellence

Vanderbilt University Medical Center’s strength in translational research, which helps “translate” scientific discovery into medical practice, was celebrated recently during the Vanderbilt Translational Research Forum

By Bill Snyder
May 6, 2021

VUMC to lead national study to treat severe COVID complications

The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been awarded a major federal grant to lead a national trial of treatments targeting the Renin Angiotensin Aldosterone System (RAAS) in patients hospitalized with COVID-19.

By Bill Snyder
April 19, 2021

VUMC aids national effort to repurpose drugs for COVID-19

Vanderbilt University Medical Center (VUMC) has been named Data Coordinating Center (DCC) for a nationwide platform of studies aimed at “repurposing” existing drugs to treat mild to moderate symptoms of COVID-19.

By Bill Snyder
April 1, 2021

Study outlines VUMC’s strategy for a learning health care system

New investments in clinical programs at Vanderbilt University Medical Center are increasingly contingent upon studies to validate claims of benefit and the potential for scalability and spread.

By Paul Govern
March 2, 2021

Study to evaluate effectiveness of COVID-19 vaccines in preventing hospitalization

As the Federal Drug Administration (FDA) considers adding a third COVID-19 vaccine to the rollout, a multicenter study led by Vanderbilt University Medical Center will evaluate how effective the vaccines are in preventing hospitalization from COVID-19.
By Kristin Smart
October 29, 2020

Self named VP for Clinical Research Networks and Strategy

Wesley Self, MD, MPH, has been appointed Vice President for Clinical Research Networks and Strategy at Vanderbilt University Medical Center.
By VUMC News and Communications
July 30, 2020

Hartmann named first Vice President for Research Integration

Katherine Hartmann, MD, PhD, Associate Dean for Clinical and Translational Scientist Development, has been named Vice President for Research Integration for Vanderbilt University Medical Center.
By Leigh MacMillan
July 23, 2020

Rice named to new leadership role for VICTR operations

Todd Rice, MD, MSc, has been appointed vice president for Clinical Trial Innovation and Operations in the Vanderbilt Institute for Clinical and Translational Research (VICTR).
By Bill Snyder
July 10, 2020

VUMC team fills COVID information gaps for web users

For the world’s web users, Vanderbilt University Medical Center is working with Google to address COVID-19 information gaps.
By Paul Govern
June 23, 2020

A connection to schizophrenia

The insula, a small region of the brain involved in diverse brain functions had widespread dysconnectivity in schizophrenia, Vanderbilt researchers found.
By Bill Snyder
April 23, 2020

VUMC team creates COVID-19 research registry

Out of the electronic health records (EHRs) of patients seen at Vanderbilt University Medical Center, a team in the Department of Biomedical Informatics is creating a COVID-19 patient registry as a platform for research.
By Paul Govern
1 2 3 4 5 … 7